Talk to a hair care advisor: 888-444-9073Viviscal: 888-444-9073Talk to Viviscal: 888-444-9073
Talk to a hair care advisor: 888-444-9073Viviscal: 888-444-9073 Talk to Viviscal: 888-444-9073
The Clinical Trials Process
RESEARCHER

Clinical Studies 2014

40 females

Clinical Studies 2013

72 females

Clinical Studies 2012

15 females

Glynis Ablon, M.D., FAAD, Ablon Skin Institute Research Center, University of California, Los Angeles, California, U.S.A.; and Steven Dayan, M.D., FACS, DeNova Research, Chicago, Illinois, U.S.A.
Thomas J. Stephens & Associates, Inc., Dallas Research Center, Carrollton, Texas, U.S.A.
Glynis Ablon, M.D., FAAD, Ablon Skin Institute Research Center, University of California, Los Angeles, California, U.S.A.
RESULTS

(In progress) 6-month, multi-center, randomized, double-blind, placebo-controlled clinical trial

Hypothesis: ingestion of oral Viviscal supplement will strengthen and promote terminal hairs in female subjects, ages 21-75, who have self-perceived thinning hair

Estimated publication date: summer 2015

6-month double-blind, placebo-controlled clinical trial demonstrated statistically significant results:

  • 18.3% reduction in hair shedding vs. placebo
  • 7.4% increase in hair thickness vs. placebo

Abstract presented: 7th World Congress for Hair Research (2013; Edinburgh, Scotland)

6-month double-blind, placebo-controlled clinical trial demonstrated statistically significant results:

  • 125% increase in terminal hairs vs. placebo group
  • 
  • Significant, self-perceived improvements in overall  hair volume, thickness and scalp coverage
  • 
  • Published: The Journal of Clinical and Aesthetic Dermatology (Nov. 2012)
 

Clinical Study Results

Clinical Study Results

Clinical Study Results

Clinical Study Results

Clinical Study Results

  1. Thomas J. Stephens & Associates, Inc.
  2. Glynis Ablon, M.D., F.A.A.D., Ablon Skin Institute Reasearch Center, University of California, Los Angeles
  3. Brook Jackson, M.D., Skin Wellness Center of Chicago
  4. Thomas J. Stephens & Associates, Inc.
  5. José Marcos Pereira, M.D., Brazil